CINXE.COM
<html><head></head><body> <div align="center"> <table width="700" border="1"><tbody><tr><td> <table width="100%" border="0"><tbody><tr> <td width="30%"><a href="https://www.worldpharmatoday.com/" target="_blank"><img src="https://www.worldpharmatoday.com/wp-content/uploads/2019/06/WPLogo.jpg" alt="World Pharma Today " width="145" height="65"></a></td> <td width="70%"> <table width="80%" border="0" align="right"> <tbody> <tr> <td style="line-height:0px" width="54"><a href="https://www.linkedin.com/company/world-pharma-today?trk=biz-companies-cym" rel="noopener noreferrer" target="_blank"><img src="https://www.worldpharmatoday.com/images/article/Weekly_newsletter/comman_images/worldpharmatoday_linkedin.png" alt="World Pharma Today Linkedin Page"></a></td> <td style="line-height:0px" width="54"><a href="https://www.facebook.com/WorldPharmaToday/" rel="noopener noreferrer" target="_blank"><img src="https://www.worldpharmatoday.com/images/article/Weekly_newsletter/comman_images/worldpharmatoday_facebook.jpg" alt="World Pharma Today Facebook Page"></a></td> <td style="line-height:0px" width="91"><a href="https://twitter.com/worldpharma2day" rel="noopener noreferrer" target="_blank"><img src="https://www.worldpharmatoday.com/images/article/Weekly_newsletter/comman_images/worldpharmatoday_twitter.png" alt="World Pharma Today Twitter Page"></a></td> <td style="background-color:#0077bb;font-family:Arial,Helvetica,sans-serif;color:#8affff;font-size:12px;text-align:center;padding:8px;font-weight:bold;text-transform:uppercase;border-radius:18px" width="194"><a style="color:#ffffff;text-decoration:none" title="Worldpharmatoday Mediapack 2018" href="http://www.worldpharmatoday.com/media-pack" rel="noopener noreferrer" target="_blank">DOWNLOAD <br> MEDIAPACK</a></td> </tr> </tbody> </table> </td> </tr></tbody></table><table width="100%" border="0" bgcolor="#0077BB"> <tbody> <tr> <td style="padding-top: 5px; padding-bottom: 5px;"><div style="text-transform: uppercase; color: #fff;" align="center"><span style="color: #ffffff; font-family: Arial,Helvetica,sans-serif; font-size: 14px; text-transform: uppercase;"><a style="color: #ffffff;" href="https://www.worldpharmatoday.com/article-submission-form/" target="_blank"><strong>Click here</strong></a><strong> to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES</strong></span></div></td> </tr> </tbody> </table> <table width="700" border="0"> <tbody><tr> <td style="padding-top: 3px; padding-bottom: 3px; text-align: center; font-size:32px"><span style = "color:#009;" ><a href="https://bit.ly/3Kb8AYb" target="_blank"><img src="https://www.worldpharmatoday.com/images/nBanners/Novel_DCT_traditional_trials.jpg" alt="Novel co-creation for novel trial design: How co-creation differs within DCTs and traditional trials" title="Novel co-creation for novel trial design: How co-creation differs within DCTs and traditional trials " width="720" height="90"></a></span></td> </tr> </tbody></table> <table width="100%" cellpadding="10px" border="0" bgcolor="#0077BB"> <tbody><tr> <td width="5%"> </td> <td width="5%"><img src="http://www.worldpharmatoday.com/images/article/Weekly_newsletter/comman_images/6.png" width="" height=""></td> <td style="color:#fff;font-size:24px;font-family:Arial,Helvetica,sans-serif" width="85%">Articles</td> <td width="5%"> </td> </tr> </tbody></table> <table width="700" border="0"> <tbody><tr> </tr> </tbody></table> <table width="100%" border="0"> <tbody><tr> <td width="5%"> </td> <td width="42%"><div align="center"><a href="https://www.worldpharmatoday.com/articles/pharma-innovations-of-2022-a-world-pharma-today-round-table/" title=" " target="_blank"><img src="http://www.worldpharmatoday.com/images/nBanners/Pharma_innovations-1.jpeg " alt="" width="280" height="180"></a></div></td> <td width="6%"> </td> <td width="42%"><p style="font-size:15px;font-family:Arial,Helvetica,sans-serif;font-weight:bold"> Pharma Innovations of 2022 – A World Pharma Today Round Table.</p> <p style="font-family:Arial,Helvetica,sans-serif;font-size:12px;line-height:18px;text-align:left;color:#666">This World Pharma Today exclusive with opinion makers is all about innovations that are in store for 2022 in the areas that have been in the headlines of late. The year that has gone by has had a phenomenal impact on the way we perceive things around us. </p> <table style="margin-bottom:15px" width="120px" cellspacing="0" cellpadding="0" border="0" align="left"> <tbody> <tr> <td style="background-color:#07b;font-family:Arial,Helvetica,sans-serif;color:rgb(255,255,255);font-size:12px;text-align:center;padding:8px;font-weight:bold;text-transform:uppercase"><a title=" MasterControl: 4 Trends Transforming the Never-Normal Future of Manufacturing " href="https://www.worldpharmatoday.com/articles/pharma-innovations-of-2022-a-world-pharma-today-round-table/" style="color:rgb(255,255,255);text-decoration:none" target="_blank">READ MORE</a></td> </tr> </tbody> </table></td> <td width="5%"> </td> </tr> </tbody></table> <table width="700" border="0"> <tbody><tr> </tr> </tbody></table> <table width="100%" cellpadding="10px" border="0" bgcolor="#0077BB"> <tbody><tr> <td width="5%"> </td> <td width="5%"><img src="http://www.worldpharmatoday.com/images/article/Weekly_newsletter/comman_images/6.png" width="" height=""></td> <td style="color:#fff;font-size:24px;font-family:Arial,Helvetica,sans-serif" width="85%">Latest News & Press Releases</td> <td width="5%"> </td> </tr> </tbody></table> <table width="100%" border="0" align="center"> <tr> <td width="5%"></td> <td width="42%"><p style="font-size: 15px; font-family: Arial,Helvetica,sans-serif; font-weight: bold;"> Oxford Join Consortium For Advance Quantum Drug Discovery.</p> <p style="font-family: Arial,Helvetica,sans-serif; font-size: 12px; line-height: 18px; text-align: left; color:#666">SEEQC, which is a digital quantum computing company, and Oxford University have partnered to ensure accelerated use of computing based on the quantum method in the research particularly focused on pharmaceuticals. </p> <table width="120px" cellspacing="0" cellpadding="0" border="0" align="left" style="margin-bottom: 15px;"> <tbody> <tr> <td style="background-color:#07b; font-family: Arial,Helvetica,sans-serif; color: rgb(138, 255, 255); font-size: 12px; text-align: center; padding: 8px; font-weight: bold; text-transform: uppercase;"><a href="https://www.worldpharmatoday.com/news/oxford-join-consortium-for-advance-quantum-drug-discovery/" title="" target="_blank" style="color: rgb(255, 255, 255); text-decoration: none;">READ MORE</a></td> </tr> </tbody> </table> <p style="font-size: 16px; font-family: Arial,Helvetica,sans-serif; font-weight: bold"> </p></td> <td width="6%"></td> <td width="47%"><p style="font-size: 16px; font-family: Arial,Helvetica,sans-serif; font-weight: bold;"><a href="https://www.worldpharmatoday.com/news/oxford-join-consortium-for-advance-quantum-drug-discovery/" target="_blank"><img src="https://www.worldpharmatoday.com/wp-content/uploads/2019/03/images_article_Drugresearch_Drug-discovery-hydpharma.jpg" alt=" " width="280" height="200"></a></a></p></td> <td width="0%"></td> <tr><td></td><td colspan="3"> <hr></td><td></td></tr> </table> <table width="100%" border="0"> <tbody><tr> <td width="5%"> </td> <td width="42%"><div align="center"><a href="https://www.worldpharmatoday.com/news/covid-19-vaccines-may-need-updation-for-omicron-who-body/" title=" " target="_blank"><img src="https://www.worldpharmatoday.com/wp-content/uploads/news/17562/VAccine_India-324x235.jpg" alt="" width="280" height="180"></a></div></td> <td width="6%"> </td> <td width="42%"><p style="font-size:15px;font-family:Arial,Helvetica,sans-serif;font-weight:bold"> COVID-19 Vaccines May Need Updation For Omicron- WHO Body.</p> <p style="font-family:Arial,Helvetica,sans-serif;font-size:12px;line-height:18px;text-align:left;color:#666">The technical body of the World Health Organization has confirmed that the COVID-19 vaccines, which the world is using currently, may have to be reworked to ensure their effectiveness against not only Omicron but future variants as well that may arise from... </p> <table style="margin-bottom:15px" width="120px" cellspacing="0" cellpadding="0" border="0" align="left"> <tbody> <tr> <td style="background-color:#07b;font-family:Arial,Helvetica,sans-serif;color:rgb(255,255,255);font-size:12px;text-align:center;padding:8px;font-weight:bold;text-transform:uppercase"><a title=" " href="https://www.worldpharmatoday.com/news/covid-19-vaccines-may-need-updation-for-omicron-who-body/" style="color:rgb(255,255,255);text-decoration:none" target="_blank">READ MORE</a></td> </tr> </tbody> </table></td> <td width="5%"> </td> </tr> <tr><td></td><td colspan="3"> <hr></td><td></td></tr> </tbody></table> <table width="100%" border="0" align="center"> <tr> <td width="5%"></td> <td width="43%"><p style="font-size: 15px; font-family: Arial,Helvetica,sans-serif; font-weight: bold;"> Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant.</p> <p style="font-family: Arial,Helvetica,sans-serif; font-size: 12px; line-height: 18px; text-align: left; color:#666">Pfizer shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease inhibitor of PAXLOVID is maintained against the SARS-CoV-2 variant Omicron. </p> <table width="120px" cellspacing="0" cellpadding="0" border="0" align="left" style="margin-bottom: 15px;"> <tbody> <tr> <td style="background-color:#07b; font-family: Arial,Helvetica,sans-serif; color: rgb(138, 255, 255); font-size: 12px; text-align: center; padding: 8px; font-weight: bold; text-transform: uppercase;"><a href="https://www.worldpharmatoday.com/news/pfizer-shares-in-vitro-efficacy-of-novel-covid-19-oral-treatment-against-omicron-variant/" title="" target="_blank" style="color: rgb(255, 255, 255); text-decoration: none;">READ MORE</a></td> </tr> </tbody> </table> <p style="font-size: 16px; font-family: Arial,Helvetica,sans-serif; font-weight: bold"> </p></td> <td width="5%"></td> <td width="42%"><p style="font-size: 16px; font-family: Arial,Helvetica,sans-serif; font-weight: bold;"><a href="https://www.worldpharmatoday.com/news/pfizer-shares-in-vitro-efficacy-of-novel-covid-19-oral-treatment-against-omicron-variant/" target="_blank"> <img src="https://www.worldpharmatoday.com/wp-content/uploads/news/21093/Delta_Omicron_Variant-324x235.jpg " alt=" " width="280" height="200"></a></p></td> <td width="5%"></td><tr><td></td><td colspan="3"> <hr></td><td></td></tr> </table> <table width="100%" border="0"> <tbody><tr> <td width="5%"> </td> <td width="42%"><div align="center"><a href="https://www.worldpharmatoday.com/news/more-than-50-of-europe-to-be-under-the-clutches-of-omicron/" title=" " target="_blank"><img src="https://www.worldpharmatoday.com/wp-content/uploads/press-releases/20959/Omicron_SARS-CoV-2-324x235.jpg" alt="" width="280" height="189"></a></div></td> <td width="6%"> </td> <td width="42%"><p style="font-size:15px;font-family:Arial,Helvetica,sans-serif;font-weight:bold"> More Than 50% of Europe To Be Under The Clutches of Omicron.</p> <p style="font-family:Arial,Helvetica,sans-serif;font-size:12px;line-height:18px;text-align:left;color:#666">According to the forecast shared by WHO top officials more than half of Europe will suffer from the highly contagious variant of COVID-19, Omicron in the next couple of months. As per one of the top line directors at WHO, there is a sweep of the west to east tidal...</p> <table style="margin-bottom:15px" width="120px" cellspacing="0" cellpadding="0" border="0" align="left"> <tbody> <tr> <td style="background-color:#07b;font-family:Arial,Helvetica,sans-serif;color:rgb(255,255,255);font-size:12px;text-align:center;padding:8px;font-weight:bold;text-transform:uppercase"><a title=" " href="https://www.worldpharmatoday.com/news/more-than-50-of-europe-to-be-under-the-clutches-of-omicron/" style="color:rgb(255,255,255);text-decoration:none" target="_blank">READ MORE</a></td> </tr> </tbody> </table></td> <td width="5%"> </td> </tr><tr><td></td><td colspan="3"> <hr></td><td></td></tr> </tbody></table> <table width="100%" border="0" align="center"> <tr> <td width="5%"></td> <td width="43%"><p style="font-size: 15px; font-family: Arial,Helvetica,sans-serif; font-weight: bold;"> AstraZeneca Sells Half-Million COVID-19 Antibody Doses To US.</p> <p style="font-family: Arial,Helvetica,sans-serif; font-size: 12px; line-height: 18px; text-align: left; color:#666">After topping off supplies to Pfizer and GlaxoSmithkline, of the COVID-19 vaccine, US has sought AstraZeneca's help of its antibody combo. Notably, the government has already bought another 500,000 doses of antibody cocktail Evusheld plus cilgavimab. </p> <table width="120px" cellspacing="0" cellpadding="0" border="0" align="left" style="margin-bottom: 15px;"> <tbody> <tr> <td style="background-color:#07b; font-family: Arial,Helvetica,sans-serif; color: rgb(138, 255, 255); font-size: 12px; text-align: center; padding: 8px; font-weight: bold; text-transform: uppercase;"><a href="https://www.worldpharmatoday.com/news/astrazeneca-sells-half-million-covid-19-antibody-doses-to-us/" title="" target="_blank" style="color: rgb(255, 255, 255); text-decoration: none;">READ MORE</a></td> </tr> </tbody> </table> <p style="font-size: 16px; font-family: Arial,Helvetica,sans-serif; font-weight: bold"> </p></td> <td width="5%"></td> <td width="42%"><p style="font-size: 16px; font-family: Arial,Helvetica,sans-serif; font-weight: bold;"><a href="https://www.worldpharmatoday.com/news/astrazeneca-sells-half-million-covid-19-antibody-doses-to-us/" target="_blank"> <img src="https://www.worldpharmatoday.com/wp-content/uploads/press-releases/16560/AstraZeneca_COVID-19-324x235.jpg" alt=" " width="280" height="200"></a></p></td> <td width="5%"></td><tr><td></td><td></td></tr> <tr><td></td><td colspan="3"> <hr></td><td></td></tr> </table> <table width="100%" border="0"> <tbody><tr> <td width="5%"> </td> <td width="42%"><div align="center"><a href="https://www.worldpharmatoday.com/news/cystic-fibrosis-treatment-approved-by-european-commission/" title=" " target="_blank"><img src="https://www.worldpharmatoday.com/wp-content/uploads/news/21173/CF_child-324x235.jpg" alt="" width="280" height="189"></a></div></td> <td width="6%"> </td> <td width="42%"><p style="font-size:15px;font-family:Arial,Helvetica,sans-serif;font-weight:bold"> Cystic Fibrosis Treatment Approved By European Commission .</p> <p style="font-family:Arial,Helvetica,sans-serif;font-size:12px;line-height:18px;text-align:left;color:#666">When it comes to cystic fibrosis, which is a debilitating and progressive condition found in around 11000 people in the UK, no cure has been attained. The EC, as it has come to notice, has granted a label extension approval for Kaftrio in a fusio.. </p> <table style="margin-bottom:15px" width="120px" cellspacing="0" cellpadding="0" border="0" align="left"> <tbody> <tr> <td style="background-color:#07b;font-family:Arial,Helvetica,sans-serif;color:rgb(255,255,255);font-size:12px;text-align:center;padding:8px;font-weight:bold;text-transform:uppercase"><a title=" " href="https://www.worldpharmatoday.com/news/cystic-fibrosis-treatment-approved-by-european-commission/" style="color:rgb(255,255,255);text-decoration:none" target="_blank">READ MORE</a></td> </tr> </tbody> </table></td> <td width="5%"> </td> </tr> </tbody></table> <hr> <table width="700" border="0"> <tbody><tr> <td style="padding-top: 1px; padding-bottom: 3px; text-align: center; font-size:32px"><span style = "color:#009;" ><a href="https://bit.ly/3Kb8AYb" target="_blank"><img src="https://www.worldpharmatoday.com/images/nBanners/Novel_DCT_traditional_trials.jpg" alt="Novel co-creation for novel trial design: How co-creation differs within DCTs and traditional trials " width="720" height="90"></a></span></td> </tr> </tbody></table> <table width="100%" border="0" bgcolor="#0077BB"> <tbody><tr><td width="5%"> </td> <td style="color:#FFF; font-family:Arial, Helvetica, sans-serif; font-size:12px" width="42%"><br><span style="font-weight:bold; font-size:14px"> Advertising:</span><br><br> <a href="mailto:kathryn@worldpharmatoday.com?subject=World%Pharma%20Today-Weekly%20Updates" style="color: #FFF;" target="_blank">kathryn@worldpharmatoday.com</a><br> <br> Phone: + 91 88268 49084<br><br><br></td> <td width="6%"> </td> <td style="color:#FFF; font-family:Arial, Helvetica, sans-serif; font-size:12px" width="42%">For the latest visit: <span class="power" style="font-weight:bold"><a href="https://www.worldpharmatoday.com/" target="_blank" style="color: white">https://www.worldpharmatoday.com/</a><a href="https://www.worldpharmatoday.com/" class="power"></a></span><br> <br> <a href="https://www.worldpharmatoday.com/" target="_blank"><img src="https://www.worldpharmatoday.com/wp-content/uploads/2019/06/WPLogo.jpg" alt="World Pharma Today" width="145" height="65"></a><a href="https://www.worldpharmatoday.com/" target="_blank"></a><br></td> <td width="5%"> </td> </tr><tr><td> </td> </tr></tbody></table></td> </tr></tbody></table> </div> </body></html>